Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
Europe
EU
Quantum Genomics (ALQGC)
Quantum Genomics (ALQGC) News

ALQGC

Quantum Genomics (ALQGC)

Quantum Genomics

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:ALQGC

1

Date	Time	Source	Headline	Symbol	Company
10/28/2022	2:00AM	GlobeNewswire Inc.	Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments	EU:ALQGC	Quantum Genomics
10/06/2022	12:00PM	GlobeNewswire Inc.	Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share	EU:ALQGC	Quantum Genomics
10/05/2022	12:00PM	GlobeNewswire Inc.	Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity	EU:ALQGC	Quantum Genomics
09/26/2022	10:06AM	GlobeNewswire Inc.	Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension	EU:ALQGC	Quantum Genomics
06/27/2022	12:47PM	GlobeNewswire Inc.	Quantum Genomics announces the appointment of its new Scientific Advisory Board	EU:ALQGC	Quantum Genomics
05/09/2022	12:00PM	GlobeNewswire Inc.	Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH	EU:ALQGC	Quantum Genomics
05/04/2022	12:00PM	GlobeNewswire Inc.	Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs	EU:ALQGC	Quantum Genomics
04/28/2022	12:00PM	GlobeNewswire Inc.	Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update	EU:ALQGC	Quantum Genomics
04/27/2022	8:20AM	GlobeNewswire Inc.	Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€	EU:ALQGC	Quantum Genomics
04/26/2022	11:35AM	GlobeNewswire Inc.	Quantum Genomics Raises a Gross Amount of Approximately € 15 M	EU:ALQGC	Quantum Genomics
03/31/2022	12:00PM	GlobeNewswire Inc.	Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606	EU:ALQGC	Quantum Genomics
03/28/2022	1:35PM	GlobeNewswire Inc.	Quantum Genomics Announces Granting of New Patents Protecting QGC606	EU:ALQGC	Quantum Genomics
03/14/2022	1:00PM	GlobeNewswire Inc.	Stéphane Cohen Joins Quantum Genomics as Director of Global Operations	EU:ALQGC	Quantum Genomics
12/06/2021	2:00AM	GlobeNewswire Inc.	Quantum Genomics Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Industries Julphar	EU:ALQGC	Quantum Genomics
11/25/2021	12:00PM	GlobeNewswire Inc.	Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.	EU:ALQGC	Quantum Genomics
10/07/2021	12:00PM	GlobeNewswire Inc.	Quantum Genomics and its Partners Reach a New Stage of Development in Asia	EU:ALQGC	Quantum Genomics
08/27/2021	4:45AM	GlobeNewswire Inc.	Quantum Genomics Presents Results from Phase IIb QUORUM Study of Firibastat in Heart Failure at the European Society of Cardiology Meeting	EU:ALQGC	Quantum Genomics
07/08/2021	2:00AM	GlobeNewswire Inc.	Quantum Genomics Enrolls First Patient in Its Pivotal Phase III REFRESH Trial of Firibastat in Difficult-to-Treat and Resista...	EU:ALQGC	Quantum Genomics
07/05/2021	2:00AM	GlobeNewswire Inc.	Presentation of the Effects of QGC606 in an Experimental Model of Heart Failure at the Annual Congress of the European Societ...	EU:ALQGC	Quantum Genomics
05/19/2021	12:40PM	GlobeNewswire Inc.	Quantum Genomics Announces the Publication of New Scientific Article in Biomedicine & Pharmacotherapy Which Further Strengthe...	EU:ALQGC	Quantum Genomics
04/28/2021	12:03PM	GlobeNewswire Inc.	Quantum Genomics Secures €3 Million Non-dilutive Financing	EU:ALQGC	Quantum Genomics
04/21/2021	2:00AM	GlobeNewswire Inc.	Quantum Genomics Will Present Top-line Results From its QUORUM Study of Firibastat in Heart Failure Post Myocardial Infarctio...	EU:ALQGC	Quantum Genomics
04/20/2021	2:00AM	GlobeNewswire Inc.	Quantum Genomics Announces the End of its Collaboration with Qilu for the Development and Commercialization of Firibastat in ...	EU:ALQGC	Quantum Genomics
03/25/2021	1:00PM	GlobeNewswire Inc.	Quantum Genomics Reports Full Year 2020 Operating and Financial Results	EU:ALQGC	Quantum Genomics
02/09/2021	12:00PM	GlobeNewswire Inc.	Orient EuroPharma Acquires Equity Stake in Quantum Genomics	EU:ALQGC	Quantum Genomics
10/09/2018	7:43AM	GlobeNewswire Inc.	Edison issues update on Quantum Genomics (ALQGC)	EU:ALQGC	Quantum Genomics
03/24/2016	8:00AM	GlobeNewswire Inc.	Quantum Genomics Raises €8.6 Million in U.S. and Europe	EU:ALQGC	Quantum Genomics
02/03/2016	2:21PM	GlobeNewswire Inc.	Quantum Genomics Expands U.S. Presence to Advance Its Development Programs for Cardiovascular Diseases	EU:ALQGC	Quantum Genomics

Showing the most relevant articles for your search:EU:ALQGC

1

Decentral Life (PK)

Rennova Health (CE)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Accredited Solutions (PK)

Bioelectronics (PK)

Lightwave Logic

Code Green Apparel (PK)

Fannie Mae (QB)

North Bay Resources (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions